Doxorubicin exposure leads to cardiac fibroblast dysregulation and worsens fibrotic remodeling in the pathological heart
Advances in cancer treatments have enabled long-term patient survival at increasing rates, however these therapies often have chronic adverse side effects of which cardiovascular disease is a major cause for concern. Specifically, patients treated with the anthracycline, doxorubicin (DOX), face sign...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Elsevier
2026-06-01
|
| Rangatū: | Journal of Molecular and Cellular Cardiology Plus |
| Ngā marau: | |
| Urunga tuihono: | http://www.sciencedirect.com/science/article/pii/S2772976126000139 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|